Forest Laboratories Inc. Logo Image

Forest Laboratories Inc.

Most Recent Annual Report

2014 Form 10K

Forest Laboratories Inc.

Forest Laboratories Inc. does not currently have any hardcopy reports available on AnnualReports.com. Click the button below to be notified when hardcopies become available.



Archived Annual Reports

About Forest Laboratories Inc.

Forest Laboratories, Inc. develops, manufactures, and sells branded and generic forms of ethical drug products. Its principal products include Lexapro for the treatment of depression in adults and adolescents, and generalized anxiety disorder in adults; Namenda for the treatment of Alzheimer's disease; Bystolic for the treatment of hypertension; and Savella for the management of fibromyalgia.

Ticker:
FRX
Exchange:
NYSE (See More NYSE Companies)
Industry:
Drug Manufacturers - Other (See More Drug Manufacturers - Other Companies)
Sector:
Healthcare (See More Healthcare Companies)

Looking for Other Annual Reports?

Search by company name or ticker symbol